Sanj Wickremasinghe

Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.

Elisa E Cornish, Kelvin Yc Teo, Mark C Gillies, Lyndell L Lim, Vuong Nguyen, Sanjeewa Wickremasinghe, Hemal Mehta, Ian L McAllister, Samantha Fraser-Bell

Journal article  |  2021  |  Br J Ophthalmol

BACKGROUND: The BEVORDEX trial compared outcomes of eyes with diabetic macular oedema (DMO) randomised to receive either intravitr..

Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study to the LEAD Clinical Trial

Zhichao Wu, Fred Kuanfu Chen, Lauren AB Hodgson, Emily Caruso, Colin A Harper, Sanjeewa S Wickremashinghe, Amy C Cohn, Pyrawy Sivarajah, Nicole Tindill, Chi D Luu, Robyn H Guymer

Journal article  |  2021  |  INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

PURPOSE: To evaluate the long-term effect of subthreshold nanosecond laser (SNL) treatment on progression to late age-related macu..

Response to correspondence from Koerner and colleagues concerning our paper entitled: The effect of diluting povidone-iodine on bacterial growth associated with speech

Sivashanth Gnanasekaran, Sophie Rogers, Sanj Wickremasinghe, Sukhpal S Sandhu

Journal article  |  2020  |  BMC OPHTHALMOLOGY

Clinicians adopt varying strategies for antisepsis with PI, which to this day remains efficient, economical and effective. Clinici..

Intravitreal injection does not change anterior chamber morphology on anterior segment optical coherence tomography.

Alp Atik, Sanjeewa S Wickremasinghe, Sukhpal S Sandhu, Ghee S Ang

Journal article  |  2020  |  Clin Exp Ophthalmol

Diabetic retinopathy progression 6 months post-cataract surgery with intravitreous bevacizumab vs triamcinolone: A secondary analysis of the DiMECAT trial

Muhammad B Sasongko, Sophie Rogers, Marios Constantinou, Sukhpal S Sandhu, Sanjeewa S Wickremasinghe, Salmaan Al-Qureshi, Lyndell L Lim

Journal article  |  2020  |  CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

IMPORTANCE: Diabetic retinopathy (DR) may progress following cataract surgery due to surgery-induced inflammation. The effect of i..

The association between intravitreal ranibizumab therapy and serum cytokine concentrations in patients with diabetic macular edema

Sivashanth Gnanasekaran, Esther Bandala-Sanchez, Maria Kolic, Leonid Churilov, Sophie L Rogers, Annie K McAuley, Sukhpal S Sandhu, Salmaan Qureshi, Lyndell L Lim, Sanjeewa S Wickremasinghe

Journal article  |  2020  |  MOLECULAR VISION

Aim: To investigate the association between intravitreal ranibizumab therapy and serum cytokine concentrations in patients with di..

A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion - an 18-month prospective cohort study

Roderick O'Day, Noha Ali, Lyndell L Lim, Sukhpal Sandhu, Thuy Chau, Sanjeewa Wickremasinghe

Journal article  |  2020  |  BMC OPHTHALMOLOGY

BACKGROUND: To evaluate the safety and efficacy of a treat-and-extend protocol of aflibercept for cystoid macular oedema (CMO) sec..

Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report

Zhichao Wu, Chi D Luu, Lauren AB Hodgson, Emily Caruso, Kate H Brassington, Nicole Tindill, Khin Zaw Aung, Colin A Harper, Sanjeewa S Wickremasinghe, Sukhpal S Sandhu, Myra B McGuinness, Fred K Chen, Usha Chakravarthy, Jennifer J Arnold, Wilson J Heriot, Shane R Durkin, Maximilian WM Wintergerst, Shekoufeh Gorgi Zadeh, Thomas Schultz, Robert P Finger, et al.

Journal article  |  2019  |  OPHTHALMOLOGY RETINA

PURPOSE: To evaluate the secondary and exploratory outcomes of the Laser Intervention in Early Stages of Age-Related Macular Degen..

Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results

Rathika Kandasamy, Marios Constantinou, Sophie L Rogers, Sukhpal Singh Sandhu, Sanjeewa Wickremasinghe, Salmaan Al-Qureshi, Lyndell L Lim

Conference Proceedings  |  2019  |  BRITISH JOURNAL OF OPHTHALMOLOGY

AIM: To report the 6-month results of a clinical trial that compared intravitreous bevacizumab (BVB) 1.25 mg versus triamcinolone ..

Twelve month results of the DIMECAT trial: a prospective, randomized clinical trial of intravitreous bevacizumab vs triamcinolone in patients with diabetic macular oedema at the time of cataract surgery

Lyndell Lim, Sophie Rogers, Marios Constantinou, Sukhpal Sandu, Sanjeewa Wickremasinghe, Salmaan Al-Qureshi

Conference Proceedings  |  2019  |  CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY